In-vivo therapeutic efficacy trial with artemisinin derivative, buparvaquone and imidocarb dipropionate against Babesia equi infection in donkeys.

The therapeutic efficacy of imidocarb, artesunate, arteether, buparvaquone and arteether+buparvaquone combination was evaluated against Babesia equi of Indian origin in splenectomised donkeys with experimentally induced acute infection. Efficacies of these drugs were tested by administering each drug or drug combination to groups of donkeys (having three donkeys each group). One group of donkey was kept as untreated control for comparing the results. Parasitaemia, haematology (WBC, RBC, PCV, granulocytes and haemoglobin), biochemical parameters (SAST, SALT, alkaline phosphatase, albumin/globulin ratio) were monitored at regular intervals. Individually, arteether and buparvaquone were found to have no parasite clearing efficacy and the treated animals died within 5-6 days after showing high parasitaemia and clinical symptoms of the disease. However, artesunate treated animals were able to restrict the parasite multiplication but only during the treatment period. Animals treated with imidocarb and arteether+buparvaquone combination were able to clear the parasite from the blood circulation after 2-5 days post-treatment (PT). After 55-58 days PT, recrudescence of B. equi parasite was observed in both these groups and a mean survival period of 66 days and 69 days, respectively, was recorded in these groups. Results of haemato-biochemical parameters had shown that imidocarb had deleterious effect on the liver function while on the other hand arteether+buparvaquone combination was found to be safe. This limited study indicates that arteether+buparvaquone combination could be a better choice than imidocarb for treating B. equi infection, but further trials are required in detail.

Medicinal herbs: a potential source of toxic metal exposure for man and animals in India.

To explore the possibility of translocation of heavy metals into humans and animals, the authors studied 28 commonly used medicinal plants and estimated their heavy metal content. The plant materials were collected from the same sources used by traditional healers and commercial drug manufacturers. The plants were identified, authenticated, and processed for the analysis of toxic metals. Lead and cadmium levels were estimated in leaf, stem bark, root, or seeds, depending on the medicinal value of the plant portion. The authors used an atomic absorption spectrophotometer to determine levels of metals. The mean lead concentration in medical herbs ranged between 2.624 ppm (standard deviation = 0.426) and 32.757 (standard deviation = 0.124 ppm), and the cadmium concentration ranged between 0.056 ppm (standard deviation = 0.002) and 0.419 ppm (standard deviation = 0.006). Interestingly, the heavy metal concentrations (i.e., lead and cadmium) were higher in leaf than in stem bark or roots, and the lowest values were recorded in seeds. No published reports on the permissible level of toxic metals in commonly used medicinal plants of India have come to the authors' attention; therefore, it was difficult for the authors to determine the role of toxic metals in drug-induced health hazards. However, the presence of toxic metals in different plants led to the conclusion that prolonged consumption of such medicinal plants may be detrimental to health.